Pomalyst ^*

Pomalyst is an oral medication primarily used to treat adults with multiple myeloma, a cancer of plasma cells. It is specifically for patients whose disease has come back (relapsed) or no longer responds to other treatments (refractory). Pomalyst is often combined with other medicines like dexamethasone to help control the cancer's growth and manage symptoms more effectively.

Pomalyst should be taken exactly as your doctor prescribes, which is typically once a day at the same time. The capsules should be swallowed whole with a glass of water and can be consumed with or without food. You must not break, chew, or open the capsules, as the powder inside can be harmful if inhaled or touched.

If you miss a dose of Pomalyst, you should take your next dose at its regularly scheduled time on the following day. You should never take two doses at once to make up for a missed one. If you are ever unsure what to do after missing a dose, contact your doctor or pharmacist for guidance on how to proceed with your treatment schedule.

Pomalyst may interact with alcohol, potentially increasing side effects like dizziness, confusion, or drowsiness. It is generally advisable to limit or completely avoid alcohol consumption during your treatment. Always discuss your alcohol use with your doctor to understand the specific risks and receive personalized recommendations for your health and safety while on this medication.

Pomalyst commonly causes side effects such as fatigue or weakness due to low red blood cell counts (anemia). Other frequent unwanted effects include constipation, nausea, diarrhea, shortness of breath, and an increased risk of infections like pneumonia. Numbness or tingling in the hands and feet, known as peripheral neuropathy, may also occur during treatment.

Pomalyst is considered a targeted oral anti-cancer therapy and an immunomodulatory agent. It works differently from traditional intravenous chemotherapy by helping the immune system fight cancer cells and stopping tumors from growing new blood vessels. This action helps slow the progression of multiple myeloma, often with a different side effect profile than many older chemotherapy drugs.

Pomalyst is typically taken in 21 or 28-day cycles for as long as it is helping to control your multiple myeloma and the side effects are tolerable. Your oncologist will monitor your progress with regular blood tests and check-ups to determine the appropriate duration of your treatment. You should not stop taking Pomalyst without specific instructions from your doctor.

Pomalyst can significantly increase your risk of developing serious blood clots, such as deep vein thrombosis (DVT) in the legs or pulmonary embolism (PE) in the lungs. Your doctor will likely prescribe a blood-thinning medication to help prevent this. You should seek immediate medical help if you experience chest pain, sudden shortness of breath, or painful swelling in one leg.

Pomalyst is distributed under a mandatory safety program in the U.S. called REMS (Risk Evaluation and Mitigation Strategy) because it can cause severe birth defects. This program requires that doctors, patients, and pharmacies are certified and aware of the risks. For example, female patients must have regular pregnancy tests and commit to using effective contraception during treatment.

Pomalyst should be stored safely at room temperature, below 25°C (77°F), in its original blister pack and carton to protect it from light and moisture. It is very important to keep this medication in a secure place, out of the reach and sight of children and pets. Do not use any capsules that are past their expiration date.

Pomalyst does affect the immune system as part of its main mechanism of action. It works by enhancing the immune system's natural ability to identify and destroy myeloma cells. However, it can also lower your white blood cell count (neutropenia), which is crucial for fighting infections. This can increase your susceptibility to getting sick, so your doctor will monitor your blood counts closely.

Pomalyst is known to cause severe, life-threatening birth defects or fetal death, so you absolutely must not get pregnant while taking it. Women who can become pregnant must use two different effective forms of birth control, starting four weeks before treatment and continuing for four weeks after stopping. Regular pregnancy tests are mandatory during treatment.

Pomalyst is most often prescribed as part of a combination therapy to increase its effectiveness. It is commonly used with a corticosteroid medication called dexamethasone. For some patients, a doctor may also add a proteasome inhibitor, such as bortezomib, to the treatment regimen. This multi-drug approach is standard for relapsed multiple myeloma.